Christopher P Locher - JoVE Visualize

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

Antimicrobial Agents and Chemotherapy|December 24, 2014

The efflux pump inhibitor timcodar improves the potency of antimycobacterial agentsTrudy H Grossman, Carolyn M Shoen, Steven M Jones, et al.

Vaccine|May 2, 2009

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccineLesley C Dupuy, Christopher P Locher, Madan Paidhungat, et al.

The Journal of Biological Chemistry|January 30, 2015

Mycobacterial nicotinate mononucleotide adenylyltransferase: structure, mechanism, and implications for drug discoveryIrina A Rodionova, Harmon J Zuccola, Leonardo Sorci, et al.

Journal of Virology|December 13, 2002

Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboonsChristopher P Locher, Stephanie A Witt, Brian G Herndier, et al.

Vaccine|May 20, 2004

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infectionChristopher P Locher, Stephanie A Witt, Brittany M Ashlock, et al.

Plos Pathogens|February 13, 2015

Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environmentBrian C VanderVen, Ruth J Fahey, Wonsik Lee, et al.

Antimicrobial Agents and Chemotherapy|December 24, 2014

A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.

Bioorganic & Medicinal Chemistry Letters|August 6, 2017

2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007

Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseasesAmy D Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun, et al.

Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

Antimicrobial Agents and Chemotherapy|December 24, 2014

The efflux pump inhibitor timcodar improves the potency of antimycobacterial agentsTrudy H Grossman, Carolyn M Shoen, Steven M Jones, et al.

Vaccine|May 2, 2009

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccineLesley C Dupuy, Christopher P Locher, Madan Paidhungat, et al.

The Journal of Biological Chemistry|January 30, 2015

Mycobacterial nicotinate mononucleotide adenylyltransferase: structure, mechanism, and implications for drug discoveryIrina A Rodionova, Harmon J Zuccola, Leonardo Sorci, et al.

Journal of Virology|December 13, 2002

Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboonsChristopher P Locher, Stephanie A Witt, Brian G Herndier, et al.

Vaccine|May 20, 2004

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infectionChristopher P Locher, Stephanie A Witt, Brittany M Ashlock, et al.

Plos Pathogens|February 13, 2015

Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environmentBrian C VanderVen, Ruth J Fahey, Wonsik Lee, et al.

Antimicrobial Agents and Chemotherapy|December 24, 2014

A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.

Bioorganic & Medicinal Chemistry Letters|August 6, 2017

2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007

Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseasesAmy D Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun, et al.

Pageof 2